[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Generation Next Fertility\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":76},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100594522","ovarian-prp-injections-for-improved-embryo-quality-using-embryo-quality-score-100594522",false,"NCT07020546","Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score","Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study","Inclusion Criteria:\n\n* No none contraindications to IVF or PRP treatment\n* Adequate ovarian reserves and AMH level\n* Willingness to undergo two IVF cycles and oPRP treatment\n\nExclusion Criteria:\n\n* Anovulation due to menopause or perimenopause\n* Any health conditions that are contraindicated for IVF or oPRP treatment",true,"FEMALE","18 Years","47 Years",{"count":21,"type":22},180,"ESTIMATED","INTERVENTIONAL",[25],"NA","Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.",[28,29,30,31],"Infertility","Poor Ovarian Reserve","Embryo Growth Disorder","in Vitro Fertilization","RECRUITING","2025-07-08",{"date":35,"type":36},"2025-07-09","ACTUAL",{"date":33,"type":36},{"date":39,"type":22},"2026-08-30",{"name":41,"class":42},"Generation Next Fertility","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":43},"100500007","ovarian-prp-for-diminished-ovarian-reserve-100500007","NCT05790655","Ovarian PRP for Diminished Ovarian Reserve","Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial","oPRP","Inclusion Criteria:\n\n* Clinical diagnosis of diminished ovarian reserve\n* Clinical diagnosis of poor ovarian response\n* Women age 35-42\n\nExclusion Criteria:\n\n* Clinical diagnosis of premature ovarian failure\n* Clinical diagnosis of menopause.\n* Under 35 years of age\n* Over 42 years of age","35 Years","42 Years",{"count":55,"type":22},230,[25],"This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.",[59],"Diminished Ovarian Reserve",[61,62,63,64,65,66,67],"Ovarian Platelet Rich Plasma","DOR","Ovarian PRP","IVF","PRP","PGT-A","ICSI","2025-02-11",{"date":70,"type":36},"2025-02-13",{"date":72,"type":36},"2023-10-07",{"date":74,"type":22},"2025-12-31",{"name":41,"class":42},""]